Tag: Shanghai Henlius Biotech Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Shanghai Henlius Biotech Inc.

The NDA of the Novel Anti-PD-1 mAb Serplulimab of Henlius Accepted by NMPA and Proposed to ...

Added to Collection on: 2021-04-22 13:07:30

Tags for this article:

Clinical medicine
Medicine
Cancer treatments
Breakthrough therapy
Orphan drugs
Oncology
Cancer immunotherapy
Cancer
Microsatellite instability
Pembrolizumab
DNA mismatch repair
Non-small-cell lung carcinoma
Henlius
Shanghai
Shanghai Henlius Biotech Inc.
China

Click the tags to see associated articles and topics

View Article Details
Henlius Receives IND Approval from NMPA for a Phase 1b/2 Clinical Trial of Its Novel PD ...

Added to Collection on: 2024-12-06 21:56:08

Tags for this article:

Cancer immunotherapy
Antineoplastic drugs
Immune system
Clusters of differentiation
Biotechnology
Antibody-drug conjugate
Checkpoint inhibitor
Immunotherapy
Targeted therapy
Programmed cell death protein 1
PD-L1
PD-1 and PD-L1 inhibitors
Henlius
Shanghai Henlius Biotech Inc.
PD
2696.HK

Click the tags to see associated articles and topics

View Article Details
Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung ...

Added to Collection on: 2025-02-05 17:14:48

Tags for this article:

Lung cancer
Orphan drugs
Small-cell carcinoma
Atezolizumab
Serplulimab
Non-small-cell lung cancer
Checkpoint inhibitor
Bevacizumab
Cancer
Programmed cell death protein 1
Treatment of lung cancer
Combined small-cell lung carcinoma
Henlius
Shanghai
Shanghai Henlius Biotech Inc.
2696.HK
China

Click the tags to see associated articles and topics

View Article Details
Shanghai Henlius Biotech's HANSIZHUANG Secures EU Approval for Lung Cancer Treatment

Added to Collection on: 2025-02-05 12:11:29

Tags for this article:

Lung cancer
Palantir
Shanghai Henlius Biotech Inc.
Novo Nordisk

Click the tags to see associated articles and topics

View Article Details
Book a Demo